Which drug first? new study aims to optimize breast cancer treatment sequence
Disease control
Not yet recruiting
This study looks at the best order to give two powerful antibody-drug conjugates (ADCs) — T-DXd and SG — to people with a common type of advanced breast cancer (HR+/HER2-). After standard hormone therapy stops working, doctors are unsure which drug to use first. The study will en…
Phase: PHASE4 • Sponsor: Yan Xue • Aim: Disease control
Last updated Jun 26, 2026 14:40 UTC